Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel vs Continuous Nerve Catheters for Post-Amputation Pain
NCT05140499Phase 4Terminated
- Start
- Aug 2022
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of bupivacaine in postoperative pain. Primary endpoint: Numerical Rating Scale at 72 hours. Started Aug 2022; status: terminated.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05140499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05140499.